Literature DB >> 28837884

Macrophages induce EMT to promote invasion of lung cancer cells through the IL-6-mediated COX-2/PGE2/β-catenin signalling pathway.

Dehai Che1, Shuai Zhang1, Zihan Jing1, Lihua Shang1, Shi Jin1, Fang Liu1, Jing Shen1, Yue Li1, Jing Hu1, Qingwei Meng2, Yan Yu3.   

Abstract

Infiltration of macrophages plays a critical role in the connection between inflammation and cancer invasion; however, the molecular mechanism that enables this crosstalk remains unclear. This paper investigates a molecular link between infiltration of macrophages and metastasis of lung cancer cells. In this study, the macrophage density and cyclooxygenase-2 (COX-2) protein were examined in surgical specimens by immunohistochemistry (IHC), and the prostaglandin E2 (PGE2) levels were determined in the blood of 30 non-small cell lung cancer (NSCLC) patients using enzyme-linked immunosorbent assay (ELISA). We demonstrated that macrophage infiltration was significantly associated with elevated tumour COX-2 expression and serum PGE2 levels in NSCLC patients. Interestingly, the COX-2 and PGE2 levels as well as macrophages were poor predictors of NSCLC patient survival. THP-1-derived macrophages were co-cultured in vitro with A549 and H1299 lung cancer cells. In the co-culture process, interleukin-6 (IL-6) induced the COX-2/PGE2 pathway in lung cancer cells, which subsequently promoted β-catenin translocation from the cytoplasm to the nucleus, resulting in epithelial-mesenchymal transition (EMT) and lung cancer cell invasion. Our findings show that the IL-6-dependent COX-2/PGE2 pathway induces EMT to promote invasion of tumour cells through β-catenin activation during the interaction between macrophages and lung cancer cells, which suggests that inhibition of COX-2/PGE2 or macrophages has the potential to suppress metastasis of lung cancer cells.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  COX-2/PGE(2); EMT; IL-6; Macrophages; NSCLC; β-catenin

Mesh:

Substances:

Year:  2017        PMID: 28837884     DOI: 10.1016/j.molimm.2017.06.018

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  38 in total

Review 1.  The interplay between cancer associated fibroblasts and immune cells in the context of radiation therapy.

Authors:  Miles Piper; Adam C Mueller; Sana D Karam
Journal:  Mol Carcinog       Date:  2020-05-04       Impact factor: 4.784

Review 2.  Pro-tumorigenic functions of macrophages at the primary, invasive and metastatic tumor site.

Authors:  Elaheh Nasrollahzadeh; Sepideh Razi; Mahsa Keshavarz-Fathi; Massimiliano Mazzone; Nima Rezaei
Journal:  Cancer Immunol Immunother       Date:  2020-06-04       Impact factor: 6.968

3.  Activation of PGE2/EP2 and PGE2/EP4 signaling pathways positively regulate the level of PD-1 in infiltrating CD8+ T cells in patients with lung cancer.

Authors:  Jinhong Wang; Li Zhang; Dong Kang; Deguang Yang; Ying Tang
Journal:  Oncol Lett       Date:  2017-10-26       Impact factor: 2.967

4.  Macrophage-mediated transfer of cancer-derived components to stromal cells contributes to establishment of a pro-tumor microenvironment.

Authors:  Michinobu Umakoshi; So Takahashi; Go Itoh; Sei Kuriyama; Yuto Sasaki; Kazuyoshi Yanagihara; Masakazu Yashiro; Daichi Maeda; Akiteru Goto; Masamitsu Tanaka
Journal:  Oncogene       Date:  2018-11-20       Impact factor: 9.867

5.  Effect of preoperative chemoradiotherapy on the immunological status of rectal cancer patients.

Authors:  Kazuaki Yasui; Ryota Kondou; Akira Iizuka; Haruo Miyata; Emiko Tanaka; Tadashi Ashizawa; Takeshi Nagashima; Keiichi Ohshima; Kenichi Urakami; Masatoshi Kusuhara; Koji Muramatsu; Takashi Sugino; Ken Yamguchi; Keita Mori; Hideyuki Harada; Tetsuo Nishimura; Hiroyasu Kagawa; Yushi Yamakawa; Hitoshi Hino; Akio Shiomi; Yasuto Akiyama
Journal:  J Radiat Res       Date:  2020-09-08       Impact factor: 2.724

6.  CircRNA hsa_circ_0110102 inhibited macrophage activation and hepatocellular carcinoma progression via miR-580-5p/PPARα/CCL2 pathway.

Authors:  Xinxing Wang; Wei Sheng; Tao Xu; Jiawen Xu; Ruyi Gao; Zhenhai Zhang
Journal:  Aging (Albany NY)       Date:  2021-04-23       Impact factor: 5.682

Review 7.  New insights into the mechanisms of epithelial-mesenchymal transition and implications for cancer.

Authors:  Anushka Dongre; Robert A Weinberg
Journal:  Nat Rev Mol Cell Biol       Date:  2019-02       Impact factor: 94.444

Review 8.  Tumor organoid models in precision medicine and investigating cancer-stromal interactions.

Authors:  Ren Xu; Xiaotao Zhou; Shike Wang; Christine Trinkle
Journal:  Pharmacol Ther       Date:  2020-08-24       Impact factor: 12.310

9.  Role of TGF-β in pancreatic ductal adenocarcinoma progression and PD-L1 expression.

Authors:  S Mazher Hussain; Rita G Kansal; Marcus A Alvarez; T J Hollingsworth; Abul Elahi; Gustavo Miranda-Carboni; Leah E Hendrick; Ajeeth K Pingili; Lorraine M Albritton; Paxton V Dickson; Jeremiah L Deneve; Danny Yakoub; D Neil Hayes; Michio Kurosu; David Shibata; Liza Makowski; Evan S Glazer
Journal:  Cell Oncol (Dordr)       Date:  2021-03-10       Impact factor: 6.730

10.  MicroRNA-30a-3p acts as a tumor suppressor in MHCC-97H hepatocellular carcinoma cells by targeting COX-2.

Authors:  XueMei Yang; JiaLing Sun; HaiTao Sun; Bin Wen; MingJia Zhang; HaiYan An; WeiCong Chen; WenTing Zhao; XiaoDan Zhong; ChunYu He; Jie Pang; SongQi He
Journal:  J Cancer       Date:  2021-05-10       Impact factor: 4.207

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.